US 6803386
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
expired A61KA61K31/557A61K31/5575
Quick answer
US patent 6803386 (Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer) held by United Therapeutics Corporation expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/557, A61K31/5575